Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL VIRTUAL VISITS MARKET SIZE WAS VALUED AT USD 13.26 BILLION IN 2021 AND IS EXPECTED TO REACH USD 56.02 BILLION BY 2027, GROWING AT A CAGR OF 27.15%.
Virtual Visits Market Size, Share, & Trends Analysis Report by
- Component: Service and Hardware
- Application: General Consultation, Behavioral Health, Chronic Care Management, Urgent Care, and Others
- Patient Group: Adults and Paediatric
- Geography:: North America, APAC, Europe, Latin America, and MEA
Industry Analysis Report, Regional Outlook, Market Trends, Competitive Landscape, Share, Growth Potential & Forecast, 2022 – 2027
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
VIRTUAL VISITS MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2027) | USD 56.02 Billion |
| Market Size (2021) | USD 13.26 Billion |
| CAGR( 2022-2027) | 27.15% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Component (Service and Hardware), Application (General Consultation, Behavioral Health, Chronic Care Management, Urgent Care, and Others), Patient Group(Adults and Pediatric) |
| Geographic Analysis | North America, APAC, Europe, Latin America, and MEA |
| Countries Covered |
MARKET INSIGHTS
The global virtual visits market was valued at USD 13.26 billion in 2021 and is expected to reach USD 56.02 billion by 2027, growing at a CAGR of 27.15%. In the virtual visit, a patient or medical professional uses a computer, smartphone, or tablet to obtain a diagnosis and send a prescription to their pharmacy. The visit is completed without leaving home or the workplace and amounts to far less than the cost of an emergency room or primary care office visit. Virtual visits are available to Health Action Council members and their employees from various vendors and providers. With the increasing telehealth utilization, there is also an increase in the adoption of virtual visit platforms. From 2017 to 2019, the virtual visit doubled for Health Action Council members.
Virtual care offers an easier, faster way to find and see a provider. Less than 2% of outpatient behavioral health and medical claims have been for virtual visits. According to CDC reports, virtual care has seen a 50% increase in March 2020 and continued to increase as lockdowns continued worldwide. According to studies, about 54% of respondents prefer to use virtual health as an option for consultation or diagnosis.
Throughout the COVID-19 pandemic, people have shifted to virtual care for medical and behavioral care because of convenience, ease of schedule, and have been found safe to avoid crowded waiting rooms. A recent report shows that about 76% of people are interested in using telehealth. Even after the pandemic ends, it is expected that about 83% of patients will use virtual care.
The following factors are likely to contribute to the virtual care market growth during the forecast period:
- Rising reimbursements by insurers and the government during the COVID-19 pandemic
- Rising adoption of patient care technology and growing digitalization
- Increasing demand for personalized care in remote areas
- Increasing Prevalence of chronic diseases and aging population
Advantages of Virtual Visits
- Reduced waiting time
- It saves the traveling time
- Easy access to expertise and specialty physicians
- Reduces overall cost of healthcare and treatment
- Better disease management
The development of the telecommunication system has increased the scope of virtual care services immensely. With the introduction of virtual visit services, the growth of traditional medical diagnosis is growing at a moderate pace, especially in high-income countries where virtual visit has become a widespread practice for a consultation. The introduction of virtual visits has led to cost-effective treatment, adoption of home healthcare services, and low expenditure on infrastructure development. The virtual visit has revolutionized the healthcare industry as it reduces hospital visits, reduces patient wait time, and decreases the physical discomfort caused to patients. Further, globally, higher expenditure on healthcare IT by the major stakeholders in the healthcare industry is contributing to the global virtual visits market growth.
The rising incidences of chronic medical conditions such as diabetes and hypertension influence market growth. Virtual care is a valuable tool for continuous monitoring of chronic diseases and treatment. The adoption of virtual visit services is expected to rise with advancements in technology and high penetration of internet connectivity with more incredible speed & smart gadgets. Communication technologies (ICTs) and Modern information, such as computers, laptops, the Internet, and smartphones, are revolutionizing the communication among people that seek and exchange information and enriching their lives.
Artificial intelligence (AI) will add value and promote the virtual visit market growth. Artificial Intelligence paired with telehealth had been on the rise before the COVID-19, which created increased virtual visits capacity.
VENDORS' ACTIVITIES IN THE MARKET
The global virtual care market is highly dynamic and fragmented, with the presence of several international, regional, and local players. The key players in the market are AMD Global Telemedicine, American Well, Koninklijke Philips, and Teladoc Health.
- Expansion activities (facility expansions and regional business) are helping players strengthen their market share and global distribution networks, thus allowing them to explore untapped opportunities.
- Large-scale investments in the single-use bioprocessing probes and sensors market through varied conglomerates and investments firms
- Forging partnerships and collaborations with well-established manufacturers cementing the footprints of the players
- Active mergers and acquisitions play a vital role in the smooth functioning of the growth cycle.
- The market is experiencing a surge in technological advancements in virtual care and the launch of new software and integrated hardware or devices or connected healthcare devices.
- Vendors invest highly in integrating hardware or connected devices, software, and applications.
- Key vendors operating in the market have demonstrated that they can provide reliable healthcare platforms to a large pool of patients at low cost or even zero cost per visit with the qualifying insurance plan in the US, depending on the type of visit.
- Some key vendors offer services 24/7 in urgent care and provide on-demand video visits.
- Many start-up companies are entering the market with the increased funding being received by the government and the private entities with innovative virtual visits platforms and solutions to gain traction among end-users
- The key players make substantial R&D investments and develop innovative and technologically advanced products, thereby restricting small and medium-sized vendors from capturing higher market shares.
MARKET GROWTH ENABLERS
- Rising reimbursements by insurers and the government during the COVID-19 pandemic
- Rising adoption of patient care technology and growing digitalization
- Increasing demand for personalized care in remote areas
- Increasing Prevalence of chronic diseases and aging population
IMPACT OF COVID-19 PANDEMIC
Before the COVID-19 pandemic, the adoption of virtual visits remained low due to a lack of reimbursement, awareness, and internet connectivity. Also, there was a limited number of healthcare providers offering virtual visit services to medical professionals and patients. Telehealth had been around for years before the COVID-19 crisis; there are many regulatory bodies and state parity laws that limited reimbursement by Medicare, Medicaid, and private insurers, curbed allowable sites of care, and placed licensure restrictions on who can provide telehealth services.
Virtual visit services have increased during the COVID-19 pandemic worldwide; the government is permitted to make consultations via virtual visit platforms by relaxing the regulations and increasing reimbursements.
With the surge in COVID-19 cases, the virtual care market jumped from 30% in 2020 to 33% in 2021, while satisfaction with asynchronous telehealth services leveraging pictures and videos grew from 41% to 54% in the same period. In 2020, 53% of US patients said they were more satisfied with live video than with previous in-person interactions.
MARKET SEGMENT ANALYSIS
The service segment is the fastest-growing segment by component, with the highest revenue of USD 10.35 billion in 2021, whereas hardware and software generated $2.91 billion. Several vendors offer a wide range of services in various specialties. The healthcare providers provide services giving both the options of a scheduled or on-demand visit. The services have widely been adopted in high-income countries and are also expected to gain momentum in low-and-middle-income countries. The hardware and software segment is expected to grow at an excellent pace in the forecast period, with a CAGR of 26.20%.
General consultation is the fastest-growing segment, with a CAGR of 25.90%. There were full restrictions worldwide to go outside, and fear of getting COVID-19 infection within hospitals led to increased virtual visits worldwide. The chronic care management market is expected to grow due to the increasing prevalence of chronic diseases and the increasing elderly population. Chronic care management services also give cost-benefit as most of the service fee is cut to as low as $0, depending on the patient's insurance plan, thus saving the overall visit cost. Also, initiatives are increasing support for chronic care management virtual visit services.
Adults are the fastest-growing patient group because of their increasing use of virtual visits. The high population and increasing chronic diseases among adults, especially in the geriatric population, have increased the demand for virtual visits. The use of virtual visit platforms and services is very high among adults from high-income countries with good infrastructure, good internet access, and awareness. The pediatric group is expected to grow at a CAGR of 23.85% during the forecast period.
GEOGRAPHICAL ANALYSIS
North America and Europe have the highest adoption rate of telehealth services due to high internet connectivity, increasing reimbursements, and full insurance coverage. In addition, North America dominates the critical vendor's presence. APAC, Latin America, and the Middle East & Africa region witnessed an increase in the adoption during a pandemic. However, limited reimbursement coverage, data security, privacy concern, lack of infrastructure, and a lack of consumer awareness of telehealth services are hindering the growth of the virtual visits market in these regions.
Frequently Asked Questions
How big is the global Virtual Visits market?
What is the growth rate of the global virtual visits market?
Who are the leading players in the global virtual visits market?
Which region has the highest number of virtual visits service providers?
What is the growth rate of the hardware and software segment of the global virtual visits market?
The global virtual visits market size was valued at $13.26 billion in 2021 and is expected to reach $56.02 billion by 2027, growing at a CAGR of 27.15%.
Base Year: 2021
Forecast Year: 2022–2027
The study considers the present scenario of the virtual visits market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Major Vendors
- AMD Global Telemedicine
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- American Well
- Koninklijke Philips
- Teladoc Health
Other Prominent Vendors
- Banner Health
- Business Overview
- Product Offerings
- Beato
- Blue Sky MD
- Careclix
- Cerner
- CHI Health
- Chiron Health
- CVS Health
- Dialogue
- Doctor On Demand
- Doxy(.) ME
- Eagle Telemedicine
- Edgemed Healthcare
- eVisit
- HealthTap
- Health at Hand
- HealthHero
- Instapract
- MDLive
- MediBuddy
- MFine
- NeuroSynaptic Communications
- Nextcare
- Optum
- Plushcare
- Piedmont Healthcare
- Practo
- RO
- Reecuro Health
- SteadyMD
- SOC Telemed
- TRUDOC Healthcare
- Vidyo
- VSee
- Walmart Health Virtual Care
- Zipnosis
Segmentation by Component:
- Service
- Hardware
Segmentation by Application:
- General Consultation
- Behavioral Health
- Chronic Care Management
- Urgent Care
- Others
Segmentation by Patient Group
- Adults
- Paediatric
Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- France
- Germany
- Italy
- Spain
- APAC
- Japan
- China
- Australia
- South Korea
- India
- Latin America
- Brazil
- Mexico
- Argentina
- The Middle East and Africa
- Turkey
- UAE
- South Africa
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL VIRTUAL VISITS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 BENEFITS OF VIRTUAL VISITS
EXHIBIT 4 US ADULTS WHO OWN GADGETS 2018 (% SHARE)
EXHIBIT 5 RISE IN PATIENT-CARE TECHNOLOGY
EXHIBIT 6 GLOBAL VIRTUAL VISITS MARKET OVERVIEW
EXHIBIT 7 VIRTUAL VISITS MARKET GROWTH FACTORS
EXHIBIT 8 VIRTUAL VISITS MARKET SEGMENT BY GEOGRAPHY
EXHIBIT 9 IMPACT OF EMERGING SMART INTEGRATED DEVICES
EXHIBIT 10 IMPACT OF INCREASING GROWTH OF VIRTUAL VISITS ACTIVITIES
EXHIBIT 11 TOTAL ANNUAL REVENUES OF TELEHEALTH PLAYERS ($ BILLION)
EXHIBIT 12 TOTAL VENTURE FUNDING FOR DIGITAL HEALTH COMPANIES 2017-2020 ($ BILLION)
EXHIBIT 13 IMPACT OF INCREASING STRATEGIC PARTNERSHIPS & MERGERS/ACQUISITIONS
EXHIBIT 14 IMPACT OF HIGHER REIMBURSEMENTS BY INSURERS AND GOVERNMENTS FOR VIRTUAL VISITS
EXHIBIT 15 VIRTUAL VISITS DELIVERY BY PAYERS
EXHIBIT 16 IMPACT OF LARGER TARGET POOL OF PATIENTS REQUIRING VIRTUAL VISITS
EXHIBIT 17 BENEFITS OF VIRTUAL VISITS FOR BETTER CHRONIC DISEASE MANAGEMENT
EXHIBIT 18 IMPACT OF RISE OF VIRTUAL HOSPITALS
EXHIBIT 19 ARCHITECTURE OF VIRTUAL HOSPITAL SOLUTION
EXHIBIT 20 IMPACT OF LACK OF ACCESS TO FIXED INTERNET SERVICE
EXHIBIT 21 GLOBAL INTERNET ACCESS 2019
EXHIBIT 22 IMPACT OF LEGAL BARRIERS & LACK OF STANDARD REGULATIONS FOR VIRTUAL VISITS
EXHIBIT 23 IMPACT OF DATA SECURITY AND PRIVACY RISKS
EXHIBIT 24 US POPULATION OPINION ON ACCESS TO FOLLOWING TYPES OF INFORMATION 2019 (% SHARE)
EXHIBIT 25 GLOBAL VIRTUAL VISITS MARKET 2021–2027 ($ BILLION)
EXHIBIT 26 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT 2021 & 2027 (%)
EXHIBIT 27 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION 2021 & 2027 (%)
EXHIBIT 28 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP 2021 & 2027 (%)
EXHIBIT 29 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 30 FIVE FORCES ANALYSIS 2021
EXHIBIT 31 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 32 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT
EXHIBIT 33 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT: OVERVIEW
EXHIBIT 34 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT: GROWTH POTENTIAL
EXHIBIT 35 GLOBAL VIRTUAL VISITS BY COMPONENT – INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 36 GLOBAL VIRTUAL VISITS BY COMPONENT – ABSOLUTE GROWTH (%)
EXHIBIT 37 GLOBAL VIRTUAL VISITS MARKET BY SERVICE – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL VIRTUAL VISITS MARKET BY SERVICE 2021–2027 ($ BILLION)
EXHIBIT 39 SERVICE INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 40 GLOBAL VIRTUAL VISITS MARKET BY HARDWARE & SOFTWARE – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL VIRTUAL VISITS MARKET BY HARDWARE & SOFTWARE 2021–2027 ($ BILLION)
EXHIBIT 42 HARDWARE & SOFTWARE INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 43 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 44 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION
EXHIBIT 45 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION: OVERVIEW
EXHIBIT 46 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION: GROWTH POTENTIAL
EXHIBIT 47 GLOBAL VIRTUAL VISITS BY APPLICATION – INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 48 GLOBAL VIRTUAL VISITS BY APPLICATION – ABSOLUTE GROWTH (%)
EXHIBIT 49 SHORT-TERM, LONG-TERM, AND PREVENTIVE CARE DURING A TOTAL OF 1.49 MILLION VIRTUAL VISITS ACROSS ALL SPECIALTIES IN THE US FROM 2018-2020 (%)
EXHIBIT 50 PERCENTAGE OF ADULTS 65 AND OLDER IN SELECTED COUNTRIES WHO RECEIVED FLU SHOTS (2019)
EXHIBIT 51 GLOBAL VIRTUAL VISITS MARKET BY GENERAL CONSULTATION – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL VIRTUAL VISITS MARKET BY GENERAL CONSULTATION 2021–2027 ($ BILLION)
EXHIBIT 53 GENERAL CONSULTATION INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 54 GLOBAL VIRTUAL VISITS MARKET BY BEHAVIORAL HEALTH – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL VIRTUAL VISITS MARKET BY BEHAVIORAL HEALTH 2021–2027 ($ BILLION)
EXHIBIT 56 BEHAVIORAL HEALTH INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 57 AVERAGE WEEKLY VISIT RATES/1,000 PATIENTS BY CHRONIC CONDITIONS BEFORE (JANUARY 2018- MARCH 2020) AND DURING (MARCH 2020- JANUARY 2021) PANDEMIC (%)
EXHIBIT 58 GLOBAL VIRTUAL VISITS MARKET BY CHRONIC CARE MANAGEMENT – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL VIRTUAL VISITS MARKET BY CHRONIC CARE MANAGEMENT 2021–2027 ($ BILLION)
EXHIBIT 60 CHRONIC CARE MANAGEMENT INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 61 GLOBAL VIRTUAL VISITS MARKET BY URGENT CARE 2021–2027 ($ BILLION)
EXHIBIT 62 GLOBAL VIRTUAL VISITS MARKET BY URGENT CARE – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 63 URGENT CARE INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 64 MOST COMMON SKIN DISEASES FOUND IN A STUDY OF 2,701 INDIVIDUALS 2019 (%)
EXHIBIT 65 GLOBAL VIRTUAL VISITS MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 66 GLOBAL VIRTUAL VISITS MARKET BY OTHERS – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 67 OTHERS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 68 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027
EXHIBIT 69 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP
EXHIBIT 70 PERCENTAGES OF VIRTUAL VISITS BY AGE-GROUP WITH CANCER
EXHIBIT 71 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP: OVERVIEW
EXHIBIT 72 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP: GROWTH POTENTIAL
EXHIBIT 73 GLOBAL VIRTUAL VISITS BY PATIENT GROUP – INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 74 GLOBAL VIRTUAL VISITS BY PATIENT GROUP – ABSOLUTE GROWTH (%)
EXHIBIT 75 ADULTS CONSULTING REGULAR DERMATOLOGIST (%)
EXHIBIT 76 PERCENTAGE OF ADULTS (50-80 YEARS) WHO VISITED VIRTUAL VISITS BY SERVICE (2020)
EXHIBIT 77 GLOBAL VIRTUAL VISITS MARKET BY ADULTS 2021–2027 ($ BILLION)
EXHIBIT 78 GLOBAL VIRTUAL VISITS MARKET BY ADULTS– INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 79 ADULTS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 80 PEDIATRIC PATIENTS SEEN BY VIDEO VISITS 2020
EXHIBIT 81 GLOBAL VIRTUAL VISIT MARKET BY PEDIATRIC 2021–2027 ($ BILLION)
EXHIBIT 82 GLOBAL VIRTUAL VISITS MARKET BY PEDIATRIC– INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 83 PEDIATRIC INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 84 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 85 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY
EXHIBIT 86 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY – INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 87 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY – ABSOLUTE GROWTH (%)
EXHIBIT 88 NORTH AMERICAN VIRTUAL VISITS MARKET – KEY COUNTRIES – 2021 ($ BILLION)
EXHIBIT 89 VIRTUAL VISITS MARKET IN NORTH AMERICA 2021–2027 ($ BILLION)
EXHIBIT 90 NORTH AMERICA VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 91 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 92 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 93 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027 ($ BILLION)
EXHIBIT 95 TELEHEALTH AMBULATORY CONTACTS FOR CONTINUOUSLY ENROLLED INSURED STUDY COHORT FOR MARCH TO JUNE 2020
EXHIBIT 96 VIRTUAL VISITS MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 97 VIRTUAL VISITS MARKET IN CANADA 2021–2027 ($ BILLION)
EXHIBIT 98 EUROPE VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH ($ BILLION)
EXHIBIT 99 DISTRIBUTION OF VIDEO CONSULTATION SERVICES BY HEALTHCARE ORGANIZATIONS IN EUROPE IN 2020 BY ADOPTION STAGE
EXHIBIT 100 EUROPE VIRTUAL VISITS MARKET – KEY COUNTRIES – 2021 ($ BILLION)
EXHIBIT 101 VIRTUAL VISITS MARKET IN EUROPE 2021–2027 ($ BILLION)
EXHIBIT 102 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 103 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027
EXHIBIT 105 INCREMENTAL GROWTH IN EUROPE 2021 & 2027 ($ BILLION)
EXHIBIT 106 NARROWING OF GENERATION GAP IN USING DIGITAL TECHNOLOGIES AMONG ADULTS IN UK
EXHIBIT 107 VIRTUAL VISITS MARKET IN UK 2021–2027 ($ BILLION)
EXHIBIT 108 VIRTUAL VISITS MARKET IN FRANCE 2021–2027 ($ BILLION)
EXHIBIT 109 VIRTUAL VISITS MARKET IN GERMANY 2021–2027 ($ BILLION)
EXHIBIT 110 SHARE OF RESPONSES OF TYPE OF TELEHEALTH SOLUTIONS/SERVICES PROVIDERS PLAN TO OFFER IN THE UPCOMING YEARS (2020 SURVEY)
EXHIBIT 111 VIRTUAL VISITS MARKET IN ITALY 2021–2027 ($ BILLION)
EXHIBIT 112 VIRTUAL VISITS MARKET IN SPAIN 2021–2027 ($ BILLION)
EXHIBIT 113 APAC VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH ($ BILLION)
EXHIBIT 114 APAC VIRTUAL VISITS MARKET – KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 115 VIRTUAL VISITS MARKET IN APAC 2021–2027 ($ BILLION)
EXHIBIT 116 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 117 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 118 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027
EXHIBIT 119 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 120 VIRTUAL VISITS MARKET IN JAPAN 2021–2027 ($ BILLION)
EXHIBIT 121 VIRTUAL VISITS MARKET IN CHINA 2021–2027 ($ BILLION)
EXHIBIT 122 VIRTUAL VISITS MARKET IN AUSTRALIA 2021–2027 ($ BILLION)
EXHIBIT 123 VIRTUAL VISITS MARKET IN SOUTH KOREA 2021–2027 ($ BILLION)
EXHIBIT 124 TELECONSULTATIONS IN DIFFERENT SPECIALTY IN 2020 (%)
EXHIBIT 125 VIRTUAL VISITS MARKET IN INDIA 2021–2027 ($ BILLION)
EXHIBIT 126 LATIN AMERICA VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 127 LATIN AMERICA VIRTUAL VISITS MARKET – KEY COUNTRIES – 2021 ($ BILLION)
EXHIBIT 128 VIRTUAL VISITS MARKET IN LATIN AMERICA 2021–2027 ($ BILLION)
EXHIBIT 129 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 130 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 131 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027
EXHIBIT 132 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 133 BRAZIL: INTERNET USER PENETRATION 2017-2026
EXHIBIT 134 VIRTUAL VISITS MARKET IN BRAZIL 2021–2027 ($ BILLION)
EXHIBIT 135 NUMBER OF VIDEO CONSULTATION BY SPECIALTY 2021 (%)
EXHIBIT 136 VIRTUAL VISITS MARKET IN MEXICO 2021–2027 ($ BILLION)
EXHIBIT 137 VIRTUAL VISITS MARKET IN ARGENTINA 2021–2027 ($ BILLION)
EXHIBIT 138 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 139 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET – KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 140 VIRTUAL VISITS MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ BILLION)
EXHIBIT 141 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 142 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 143 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027
EXHIBIT 144 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 145 VIRTUAL VISITS MARKET IN TURKEY 2021–2027 ($ BILLION)
EXHIBIT 146 VIRTUAL VISITS MARKET IN UAE 2021–2027 ($ BILLION)
EXHIBIT 147 VIRTUAL VISITS MARKET IN SOUTH AFRICA 2021–2027 ($ BILLION)
EXHIBIT 148 PURE & DIVERSIFIED PLAYERS IN THE GLOBAL VIRTUAL VISITS MARKET
EXHIBIT 149 VENDORS OFFERING VIRTUAL VISITS: MARKET DOMINANCE ANALYSIS
EXHIBIT 150 VENDORS OFFERING VIRTUAL CARE VISITS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 151 AMERICAN WELL: REVENUE 2019-2021 ($ MILLION)
EXHIBIT 152 AMERICAN WELL: TOTAL R&D EXPENDITURE 2029-2021 ($ MILLION)
EXHIBIT 153 AMERICAN WELL: TOTAL PLATFORM SUBSCRIPTION REVENUE 2029-2021 ($ MILLION)
EXHIBIT 154 AMERICAN WELL: TOTAL VISITS REVENUE 2029-2021 ($ MILLION)
EXHIBIT 155 KONINKLIJKE PHILIPS: TOTAL REVENUE 2029-2021 ($ MILLION)
EXHIBIT 156 KONINKLIJKE PHILIPS: MARKET SHARE BY REPORTABLE SEGMENTS- 2021 ($ MILLION)
EXHIBIT 157 TELADOC HEALTH: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 158 TELADOC HEALTH: US TOTAL REVENUE 2019-2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 NUMBER OF CONNECTIVE SMART DEVICES OFFERED BY AMERICAN WELL
TABLE 4 NUMBER OF INTEGRATED SMART DEVICES OFFERED BY AMERICAN WELL
TABLE 5 CAPITAL RAISE BY THE COMPANIES IN THE FIELD OF VIRTUAL VISITS IN 2021
TABLE 6 NUMBER OF COMPANIES ENGAGED IN STRATEGIC ACQUISITIONS IN THE RECENT YEARS
TABLE 7 HOUSEHOLDS IN US WITH HOME INTERNET BY CONNECTION TYPE
TABLE 8 PERCENTAGE OF 933 MILLION TELEMEDICINE VISITS ACROSS SPECIALTIES 2018-2020
TABLE 9 AMD GLOBAL TELEMEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 10 AMERICAN WELL: MAJOR PRODUCT OFFERINGS
TABLE 11 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 12 TELADOC HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 13 BANNER HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 14 BEATO: PRODUCT OFFERINGS
TABLE 15 BLUE SKY MD: MAJOR PRODUCT OFFERINGS
TABLE 16 CARECLIX: MAJOR PRODUCT OFFERINGS
TABLE 17 CERNER: MAJOR PRODUCT OFFERINGS
TABLE 18 CHI HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 19 CHIRON HEALTH: PRODUCT OFFERINGS
TABLE 20 CVS HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 21 DIALOGUE: PRODUCT OFFERINGS
TABLE 22 DOCTOR ON DEMAND: MAJOR PRODUCT OFFERINGS
TABLE 23 DOXY.ME: MAJOR PRODUCT OFFERINGS
TABLE 24 EAGLE TELEMEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 25 EDGEMED HEALTHCARE: PRODUCT OFFERINGS
TABLE 26 EVISIT: MAJOR PRODUCT OFFERINGS
TABLE 27 HEALTHTAP: MAJOR PRODUCT OFFERINGS
TABLE 28 HEALTH AT HAND: PRODUCT OFFERINGS
TABLE 29 HEALTHHERO: PRODUCT OFFERINGS
TABLE 30 INSTAPRACT: PRODUCT OFFERINGS
TABLE 31 MDLIVE: MAJOR PRODUCT OFFERINGS
TABLE 32 MEDIBUDDY: PRODUCT OFFERINGS
TABLE 33 MFINE: PRODUCT OFFERINGS
TABLE 34 NEUROSYNAPTIC COMMUNICATIONS: PRODUCT OFFERINGS
TABLE 35 NEXTCARE: MAJOR PRODUCT OFFERINGS
TABLE 36 OPTUM: MAJOR PRODUCT OFFERINGS
TABLE 37 PLUSHCARE: PRODUCT OFFERINGS
TABLE 38 PIEDMONT HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 39 PRACTO: MAJOR SERVICE OFFERINGS
TABLE 40 RO: PRODUCT OFFERINGS
TABLE 41 RECURO HEALTH: PRODUCT OFFERINGS
TABLE 42 STEADYMD: MAJOR PRODUCT OFFERINGS
TABLE 43 SOC TELEMED: MAJOR PRODUCT OFFERINGS
TABLE 44 TRUDOC HEALTH CARE: PRODUCT OFFERINGS
TABLE 45 VIDYO: MAJOR PRODUCT OFFERINGS
TABLE 46 VSEE: PRODUCT OFFERINGS
TABLE 47 WALMART HEALTH VIRTUAL CARE: MAJOR PRODUCT OFFERINGS
TABLE 48 ZIPNOSIS: MAJOR PRODUCT OFFERINGS
TABLE 49 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 50 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 51 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 52 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)
TABLE 53 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 54 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)
TABLE 55 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 56 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 57 NORTH AMERICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 58 NORTH AMERICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)
TABLE 59 NORTH AMERICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 60 NORTH AMERICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)
TABLE 61 NORTH AMERICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 62 NORTH AMERICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 63 EUROPE VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 64 EUROPE VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)
TABLE 65 EUROPE VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 66 EUROPE VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)
TABLE 67 EUROPE VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 68 EUROPE VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 69 APAC VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 70 APAC VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)
TABLE 71 APAC VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 72 APAC VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)
TABLE 73 APAC VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 74 APAC VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 75 LATIN AMERICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 76 LATIN AMERICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)
TABLE 77 LATIN AMERICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 78 LATIN AMERICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)
TABLE 79 LATIN AMERICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 80 LATIN AMERICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 81 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 82 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)
TABLE 83 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 84 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)
TABLE 85 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 86 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY COMPONENT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY PATIENT GROUP
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 PREMIUM INSIGHTS
8.1 OVERVIEW
8.1.1 VENDOR ACTIVITIES IN THE MARKET
8.1.2 FACTORS CONTRIBUTING TO MARKET GROWTH
8.1.3 IMPACT OF COVID-19 PANDEMIC
8.1.4 MARKET ANALYSIS BY SEGMENTATION
9 MARKET OPPORTUNITIES & TRENDS
9.1 EMERGING SMART INTEGRATED DEVICES
9.2 INCREASING GROWTH OF VIRTUAL VISITS ACTIVITIES
9.3 INCREASING STRATEGIC PARTNERSHIPS & MERGERS/ACQUISITIONS
10 MARKET GROWTH ENABLERS
10.1 HIGHER REIMBURSEMENTS BY INSURERS AND GOVERNMENTS FOR VIRTUAL VISITS
10.2 LARGER TARGET POOL OF PATIENTS REQUIRING VIRTUAL VISITS
10.3 RISE OF VIRTUAL HOSPITALS
11 MARKET RESTRAINTS
11.1 LACK OF ACCESS TO FIXED INTERNET SERVICE
11.2 LEGAL BARRIERS & LACK OF STANDARD REGULATIONS FOR VIRTUAL VISITS
11.3 DATA SECURITY AND PRIVACY RISKS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 COMPONENT
12.2.2 APPLICATION
12.2.3 PATIENT GROUP
12.2.4 GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 COMPONENT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SERVICE
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 HARDWARE & SOFTWARE
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 GENERAL CONSULTATION
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 BEHAVIORAL HEALTH
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 CHRONIC CARE MANAGEMENT
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 URGENT CARE
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
14.7 OTHERS
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
14.7.3 MARKET BY GEOGRAPHY
15 PATIENT GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 ADULTS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 PEDIATRIC
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: COMPONENT
17.4 NORTH AMERICA: APPLICATION
17.5 NORTH AMERICA: PATIENT GROUP
17.6 KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: COMPONENT
18.4 EUROPE: APPLICATION
18.5 EUROPE: PATIENT GROUP
18.6 KEY COUNTRIES
18.6.1 UK: MARKET SIZE & FORECAST
18.6.2 FRANCE: MARKET SIZE & FORECAST
18.6.3 GERMANY: MARKET SIZE & FORECAST
18.6.4 ITALY: MARKET SIZE & FORECAST
18.6.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: COMPONENT
19.4 APAC: APPLICATION
19.5 APAC: PATIENT GROUP
19.6 KEY COUNTRIES
19.6.1 JAPAN: MARKET SIZE & FORECAST
19.6.2 CHINA: MARKET SIZE & FORECAST
19.6.3 AUSTRALIA: MARKET SIZE & FORECAST
19.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.6.5 INDIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: COMPONENT
20.4 LATIN AMERICA: APPLICATION
20.5 LATIN AMERICA: PATIENT GROUP
20.6 KEY COUNTRIES
20.6.1 BRAZIL: MARKET SIZE & FORECAST
20.6.2 MEXICO: MARKET SIZE & FORECAST
20.6.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: COMPONENT
21.4 MIDDLE EAST & AFRICA: APPLICATION
21.5 MIDDLE EAST & AFRICA: PATIENT GROUP
21.6 KEY COUNTRIES
21.6.1 TURKEY: MARKET SIZE & FORECAST
21.6.2 UAE: MARKET SIZE & FORECAST
21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 AMD GLOBAL TELEMEDICINE
22.2.2 AMERICAN WELL
22.2.3 KONINKLIJKE PHILIPS
22.2.4 TELADOC HEALTH
23 KEY COMPANY PROFILES
23.1 AMD GLOBAL TELEMEDICINE
23.1.1 BUSINESS OVERVIEW
23.1.1 PRODUCT OFFERINGS
23.1.2 KEY STRATEGIES
23.1.3 KEY STRENGTHS
23.1.4 KEY OPPORTUNITIES
23.2 AMERICAN WELL
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 KONINKLIJKE PHILIPS
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 TELADOC HEALTH
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 BANNER HEALTH
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 BEATO
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 BLUE SKY MD
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 CARECLIX
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 CERNER
24.5.1 BUSINESS OVERVIEW
24.5.2 SERVICE OFFERINGS
24.6 CHI HEALTH
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 CHIRON HEALTH
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 CVS HEALTH
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 DIALOGUE
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 DOCTOR ON DEMAND
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 DOXY.ME
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 EAGLE TELEMEDICINE
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 EDGEMED HEALTHCARE
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 EVISIT
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 HEALTHTAP
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 HEALTH AT HAND
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 HEALTHHERO
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 INSTAPRACT
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 MDLIVE
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 MEDIBUDDY
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 MFINE
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
24.22 NEUROSYNAPTIC COMMUNICATIONS
24.22.1 BUSINESS OVERVIEW
24.22.2 PRODUCT OFFERINGS
24.23 NEXTCARE
24.23.1 BUSINESS OVERVIEW
24.23.2 PRODUCT OFFERINGS
24.24 OPTUM
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
24.25 PLUSHCARE
24.25.1 BUSINESS OVERVIEW
24.25.2 PRODUCT OFFERINGS
24.26 PIEDMONT HEALTHCARE
24.26.1 BUSINESS OVERVIEW
24.26.2 PRODUCT OFFERINGS
24.27 PRACTO
24.27.1 BUSINESS OVERVIEW
24.27.2 PRODUCT OFFERINGS
24.28 RO
24.28.1 BUSINESS OVERVIEW
24.28.2 PRODUCT OFFERINGS
24.29 REECURO HEALTH
24.29.1 BUSINESS OVERVIEW
24.29.2 PRODUCT OFFERINGS
24.30 STEADYMD
24.30.1 BUSINESS OVERVIEW
24.30.2 PRODUCT OFFERINGS
24.31 SOC TELEMED
24.31.1 BUSINESS OVERVIEW
24.31.2 PRODUCT OFFERINGS
24.32 TRUDOC HEALTH CARE
24.32.1 BUSINESS OVERVIEW
24.32.2 PRODUCT OFFERINGS
24.33 VIDYO
24.33.1 BUSINESS OVERVIEW
24.33.2 PRODUCT OFFERINGS
24.34 VSEE
24.34.1 BUSINESS OVERVIEW
24.34.2 PRODUCT OFFERINGS
24.35 WALMART HEALTH VIRTUAL CARE
24.35.1 BUSINESS OVERVIEW
24.35.2 PRODUCT OFFERINGS
24.36 ZIPNOSIS
24.36.1 BUSINESS OVERVIEW
24.36.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY COMPONENT
26.3 MARKET BY APPLICATION
26.4 MARKET BY PATIENT GROUP
26.5 NORTH AMERICA BY COMPONENT
26.6 NORTH AMERICA BY APPLICATION
26.7 NORTH AMERICA BY PATIENT GROUP
26.8 EUROPE BY COMPONENT
26.9 EUROPE BY APPLICATION
26.10 EUROPE BY PATIENT GROUP
26.11 APAC BY COMPONENT
26.12 APAC BY APPLICATION
26.13 APAC BY PATIENT GROUP
26.14 LATIN AMERICA BY COMPONENT
26.15 LATIN AMERICA BY APPLICATION
26.16 LATIN AMERICA BY PATIENT GROUP
26.17 MIDDLE EAST & AFRICA BY COMPONENT
26.18 MIDDLE EAST & AFRICA BY APPLICATION
26.19 MIDDLE EAST & AFRICA BY PATIENT GROUP
27 APPENDIX
27.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the global Virtual Visits market?
What is the growth rate of the global virtual visits market?
Who are the leading players in the global virtual visits market?
Which region has the highest number of virtual visits service providers?
What is the growth rate of the hardware and software segment of the global virtual visits market?
Other RELATED Reports
Remote Patient Monitoring Market - Global Outlook & Forecast 2022-2027
Published : April 2022
 Market - Industry Outlook and Forecast 2022-2027-1657284436.png)
U.S. Tele-Intensive Care Unit (ICU) Market - Industry Outlook and Forecast 2022-2027
Published : July 2022